Free Trial

Sigma Planning Corp Cuts Stake in The Clorox Company (NYSE:CLX)

Clorox logo with Consumer Staples background

Sigma Planning Corp lessened its stake in The Clorox Company (NYSE:CLX - Free Report) by 45.4% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 10,874 shares of the company's stock after selling 9,034 shares during the quarter. Sigma Planning Corp's holdings in Clorox were worth $1,766,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors also recently bought and sold shares of the company. Brooklyn Investment Group grew its holdings in shares of Clorox by 163.8% during the fourth quarter. Brooklyn Investment Group now owns 153 shares of the company's stock valued at $25,000 after buying an additional 95 shares during the last quarter. Prospera Private Wealth LLC bought a new position in Clorox in the 3rd quarter valued at approximately $27,000. Continuum Advisory LLC boosted its stake in Clorox by 300.0% during the 3rd quarter. Continuum Advisory LLC now owns 184 shares of the company's stock valued at $30,000 after purchasing an additional 138 shares during the last quarter. Asset Planning Inc bought a new stake in shares of Clorox in the 4th quarter worth $32,000. Finally, Catalyst Capital Advisors LLC purchased a new position in shares of Clorox in the third quarter worth $54,000. 78.53% of the stock is owned by hedge funds and other institutional investors.

Clorox Stock Performance

Shares of NYSE:CLX traded down $2.74 during mid-day trading on Monday, reaching $154.52. 1,693,548 shares of the company traded hands, compared to its average volume of 1,363,494. The Clorox Company has a 52 week low of $127.60 and a 52 week high of $171.37. The firm has a market cap of $19.03 billion, a PE ratio of 42.22, a PEG ratio of 2.62 and a beta of 0.42. The company's 50 day moving average price is $157.72 and its 200-day moving average price is $159.96. The company has a debt-to-equity ratio of 20.52, a current ratio of 0.94 and a quick ratio of 0.60.

Clorox (NYSE:CLX - Get Free Report) last posted its quarterly earnings results on Monday, February 3rd. The company reported $1.55 earnings per share for the quarter, topping analysts' consensus estimates of $1.39 by $0.16. Clorox had a net margin of 6.38% and a return on equity of 316.87%. During the same period last year, the company earned $2.16 earnings per share. On average, equities analysts expect that The Clorox Company will post 7.15 EPS for the current fiscal year.

Analyst Ratings Changes

Several equities research analysts recently commented on CLX shares. StockNews.com cut Clorox from a "buy" rating to a "hold" rating in a research report on Sunday, January 5th. JPMorgan Chase & Co. lifted their price target on shares of Clorox from $171.00 to $173.00 and gave the stock a "neutral" rating in a research note on Tuesday, February 4th. Royal Bank of Canada restated a "sector perform" rating and set a $150.00 price objective on shares of Clorox in a research report on Thursday, January 30th. Wells Fargo & Company lifted their target price on shares of Clorox from $157.00 to $161.00 and gave the stock an "equal weight" rating in a research report on Tuesday, February 4th. Finally, Barclays increased their price target on Clorox from $130.00 to $140.00 and gave the company an "underweight" rating in a report on Wednesday, February 5th. Four investment analysts have rated the stock with a sell rating, eleven have assigned a hold rating and one has assigned a buy rating to the company's stock. Based on data from MarketBeat.com, the company has a consensus rating of "Hold" and a consensus price target of $158.21.

Get Our Latest Stock Analysis on CLX

About Clorox

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Featured Articles

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Should You Invest $1,000 in Clorox Right Now?

Before you consider Clorox, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Clorox wasn't on the list.

While Clorox currently has a "Reduce" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

These Are the 3 Stocks Most Likely to SPLIT in 2025
NVIDIA Earnings: Will it Spark a Rally or Trigger a Sell-Off?
Marjorie Taylor Greene Bought THOUSANDS in Tesla Stock

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines